Erythropoietin Drugs Market to Grow US$ 11.9 Billion by 2026
Search jobs
Erythropoietin Drugs Market to Grow US$ 11.9 Billion by 2026
Pune, Maharashtra, India, February 8 2021 (Wiredrelease) Allied Analytics –:Allied Market Research published a new report, titled, “Global Erythropoietin Drugs Market is expected to garner $11.9 billion by 2020, registering CAGR of 9.7% during the forecast period 2017 – 2026.
Rising incidences of Cancer, ESRD (End Stage Renal Disease), and HIV have largely contributed to the overwhelming demand for EPO drugs. Approximately 20% of the patients suffering from Cancer/HIV and ~70% of the patients suffering from ESRD undergo chemotherapy, which induces anemia in such patients, requiring EPO treatment. Despite this, the market has nevertheless witnesses restraints due to highly priced EPO drugs resulting in minimal adoption. However, commercialization of EPO biosimilars would eventually ease the influence of restraints and fuel the market growth, primarily across the developing regions.